Literature DB >> 31511383

The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.

Zahra Kiani1,2, Franck P Dupuy1, Julie Bruneau3,4, Bertrand Lebouché1,5,6, Christelle Retière7,8, Daniel E Geraghty9, Nicole F Bernard10,2,6,11.   

Abstract

Several studies support a role for specific killer immunoglobulin-like receptor (KIR)-HLA combinations in protection from HIV infection and slower progression to AIDS. Natural killer (NK) cells acquire effector functions through education, a process that requires the interaction of inhibitory NK cell receptors with their major histocompatibility complex (MHC) class I (or HLA class I [HLA-I]) ligands. HLA-C allotypes are ligands for the inhibitory KIRs (iKIRs) KIR2DL1, KIR2DL2, and KIR2DL3, whereas the ligand for KIR3DL1 is HLA-Bw4. HIV infection reduces the expression of HLA-A, -B, and -C on the surfaces of infected CD4 (iCD4) T cells. Here we investigated whether education through iKIR-HLA interactions influenced NK cell responses to autologous iCD4 cells. Enriched NK cells were stimulated with autologous iCD4 cells or with uninfected CD4 cells as controls. The capacities of single-positive (sp) KIR2DL1, KIR2DL2, KIR2DL3, and KIR3DL1 NK cells to produce CCL4, gamma interferon (IFN-γ), and/or CD107a were assessed by flow cytometry. Overall, we observed that the potency of NK cell education was directly related to the frequency of each spiKIR+ NK cell's ability to respond to the reduction of its cognate HLA ligand on autologous iCD4 cells, as measured by the frequency of production by spiKIR+ NK cells of CCL4, IFN-γ, and/or CD107a. Both NK cell education and HIV-mediated changes in HLA expression influenced NK cell responses to iCD4 cells.IMPORTANCE Epidemiological studies show that natural killer (NK) cells have anti-HIV activity: they are able to reduce the risk of HIV infection and/or slow HIV disease progression. How NK cells contribute to these outcomes is not fully characterized. We used primary NK cells and autologous HIV-infected cells to examine the role of education through four inhibitory killer immunoglobulin-like receptors (iKIRs) from persons with HLA types that are able to educate NK cells bearing one of these iKIRs. HIV-infected cells activated NK cells through missing-self mechanisms due to the downmodulation of cell surface HLA expression mediated by HIV Nef and Vpu. A higher frequency of educated than uneducated NK cells expressing each of these iKIRs responded to autologous HIV-infected cells by producing CCL4, IFN-γ, and CD107a. Since NK cells were from non-HIV-infected individuals, they model the consequences of healthy NK cell-HIV-infected cell interactions occurring in the HIV eclipse phase, when new infections are susceptible to extinction.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HIV; KIR; NK cell education

Mesh:

Substances:

Year:  2019        PMID: 31511383      PMCID: PMC6854491          DOI: 10.1128/JVI.01185-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

Authors:  Nidale Tarek; Jean-Benoit Le Luduec; Meighan M Gallagher; Junting Zheng; Jeffrey M Venstrom; Elizabeth Chamberlain; Shakeel Modak; Glenn Heller; Bo Dupont; Nai-Kong V Cheung; Katharine C Hsu
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

2.  KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.

Authors:  William Henry Carr; Marcelo Jorge Pando; Peter Parham
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 3.  Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien; L P Cousens; T P Salazar-Mather
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

4.  Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.

Authors:  Gaëlle David; Zakia Djaoud; Catherine Willem; Nolwenn Legrand; Pauline Rettman; Katia Gagne; Anne Cesbron; Christelle Retière
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

5.  Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.

Authors:  Philomena Kamya; Salix Boulet; Christos M Tsoukas; Jean-Pierre Routy; Réjean Thomas; Pierre Côté; Mohamed-Rachid Boulassel; Jean-Guy Baril; Colin Kovacs; Stephen A Migueles; Mark Connors; Todd J Suscovich; Christian Brander; Cecile L Tremblay; Nicole Bernard
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.

Authors:  Martin Stern; Loredana Ruggeri; Marusca Capanni; Antonella Mancusi; Andrea Velardi
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113

7.  Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.

Authors:  C C Winter; J E Gumperz; P Parham; E O Long; N Wagtmann
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

8.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

9.  HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Authors:  Rujun Song; Irene Lisovsky; Bertrand Lebouché; Jean-Pierre Routy; Julie Bruneau; Nicole F Bernard
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

10.  Plasticity in the organization and sequences of human KIR/ILT gene families.

Authors:  M J Wilson; M Torkar; A Haude; S Milne; T Jones; D Sheer; S Beck; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

View more
  6 in total

1.  The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation.

Authors:  Wei Zuo; Xing-Xing Yu; Xue-Fei Liu; Ying-Jun Chang; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Su Zhao; Xiao-Jun Huang; Xiang-Yu Zhao
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

2.  Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.

Authors:  Franck P Dupuy; Nicole F Bernard; Lauren Nagel; Sanket Kant; Christopher Leeks; Jean-Pierre Routy; Cécile Tremblay; Réjean Thomas; Jason Szabo; Pierre Côté; Benoit Trottier; Roger LeBlanc; Danielle Rouleau
Journal:  J Virol       Date:  2021-09-29       Impact factor: 5.103

Review 3.  NK Cells in Protection from HIV Infection.

Authors:  Nicole F Bernard; Khlood Alsulami; Erik Pavey; Franck P Dupuy
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 4.  Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.

Authors:  Nicole F Bernard; Sanket Kant; Zahra Kiani; Cécile Tremblay; Franck P Dupuy
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

5.  Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.

Authors:  Sanket Kant; Ningyu Zhang; Alexandre Barbé; Jean-Pierre Routy; Cécile Tremblay; Réjean Thomas; Jason Szabo; Pierre Côté; Benoit Trottier; Roger LeBlanc; Danielle Rouleau; Marianne Harris; Franck P Dupuy; Nicole F Bernard
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

Review 6.  Negative Regulation and Protective Function of Natural Killer Cells in HIV Infection: Two Sides of a Coin.

Authors:  Yu Sun; Jie Zhou; Yongjun Jiang
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.